Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100: A Novel Mechanism for Regulating B Cell Signaling
Open Access
- 1 November 2000
- journal article
- research article
- Published by Elsevier
- Vol. 13 (5) , 621-631
- https://doi.org/10.1016/s1074-7613(00)00062-5
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- National Institutes of Health (CA68675)
This publication has 52 references indexed in Scilit:
- NK CELL RECEPTORSAnnual Review of Immunology, 1998
- CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast KineticsThe Journal of Experimental Medicine, 1997
- The CD19–CD21 Complex Regulates Signal Transduction Thresholds Governing Humoral Immunity and AutoimmunityImmunity, 1997
- Identification of a Novel Transmembrane Semaphorin Expressed on LymphocytesPublished by Elsevier ,1996
- Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes.The Journal of Experimental Medicine, 1996
- CD40 ligand-transduced co-stimulation of T cells in the development of helper functionNature, 1995
- The same tyrosine-based inhibition motif, in the intra-cytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activationImmunity, 1995
- Activation signals are delivered through two distinct epitopes of CD100, a unique 150 kDa human lymphocyte surface structure previously defined by BB18 mAbInternational Immunology, 1995
- B-cell signalling via the C-type lectins CD23 and CD72Immunology Today, 1994
- Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies.The Journal of Experimental Medicine, 1984